ITGA2B and cancer: However, the fact that GPIb- and GPII/IIIa-blocking antibodies demonstrated no impact on the formation of cancer cell-platelet aggregates in vitro suggests that molecules other than GPIb, GPIIb/IIIa, vWF and fibrinogen may be pivotal to their formation.